₹0.09
(Market cap
₹8 Cr
Recently Viewed
Clear AllMarket cap
₹8 Cr
Revenue (TTM)
₹110 Cr
P/E Ratio
--
P/B Ratio
1.7
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹0 Cr
ROE
-15.7 %
ROCE
-2.8 %
Industry P/E
45.99
EV/EBITDA
109.3
Debt to Equity
2.2
Book Value
₹1.2
EPS
₹-0
Face value
1
Shares outstanding
40,000,000
CFO
₹-0.06 Cr
EBITDA
₹1.30 Cr
Net Profit
₹0.07 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Vivanza Bioscience
| -5.9 | 15.0 | 4.5 | -8.8 | -50.4 | -25.5 | -11.5 |
|
BSE Healthcare
| 2.7 | 6.8 | 7.9 | 5.7 | 24.7 | 13.8 | 11.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|---|
|
Vivanza Bioscience
| -39.7 | -69.4 | -30.5 | -12.9 | 55.9 | 759.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Vivanza Bioscience
|
2.1 | 8.3 | 110.0 | -0.2 | 0.0 | -3.5 | -- | 1.7 |
| 2,822.7 | 35,289.3 | 5,201.6 | 1,014.6 | 22.9 | 25 | 34.8 | 7.7 | |
| 1,680.1 | 31,850.1 | 8,850.1 | 894.8 | 15.2 | 19.8 | 36.6 | 6.4 | |
| 1,216.4 | 5,311.2 | 6,020.3 | 132.1 | 3.2 | 6.8 | 47.1 | 3.0 | |
| 2,043.4 | 32,884.0 | 4,193.0 | 753.8 | 22.7 | 20.8 | 43.6 | 8.2 | |
| 35.9 | 15.8 | 25.3 | 0.1 | 0.4 | 2.5 | 138.6 | 3.3 | |
| 28.1 | 35.1 | 16.0 | -4.4 | -58.4 | -3.7 | -- | 0.3 | |
| 41.9 | 26.3 | 4.6 | 0.4 | 1.7 | 4 | 67.3 | 2.6 | |
| 45.4 | 24.8 | 294.6 | 2.1 | 0.9 | 163.8 | 12.1 | 9.8 | |
| 0.3 | 34.6 | 386.8 | 35.4 | 11.1 | 29.9 | 1 | 0.2 |
No Review & Analysis are available.
Wholesale of pharmaceutical and medical goods
Incorporated
1982
Chairman
--
Managing Director
JA Mehta
Headquarters
Ahmedabad, Gujarat
Website
Looking for more details about Vivanza Biosciences Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Vivanza Biosciences Ltd is ₹2.07 (BSE) as of 30-Apr-2026 IST. Vivanza Biosciences Ltd has given a return of -50.41% in the last 3 years.
Since, TTM earnings of Vivanza Biosciences Ltd is negative, P/E ratio is not available.
The P/B ratio of Vivanza Biosciences Ltd is 1.72 times as on 30-Apr-2026, a 473 premium to its peers’ median range of 0.30 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
2.01
|
|
2024
|
49.63
|
5.86
|
|
2023
|
125.69
|
18.38
|
|
2022
|
22.66
|
21.61
|
|
2021
|
69.34
|
16.53
|
The 52-week high and low of Vivanza Biosciences Ltd are Rs 2.94 and Rs 1.75 as of 01-May-2026.
Vivanza Biosciences Ltd has a market capitalisation of ₹ 8 Cr as on 30-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Vivanza Biosciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.